MedTrace Logo

Novel Bidirectional Peripheral Artery Cannula in Minimally Invasive Aortic Valve Surgery

NCT04402372 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-05-26

No results posted yet for this study

Summary

The aim of this study is to evaluate the safety and efficacy of the novel bidirectional cannula (BiflowTM, LivaNova, Italy) with specific design to ensure stable distal perfusion compared to conventional cannula with downstream line in patients undergoing femoral arterial cannulation for cardiopulmonary bypass during minimally invasive surgery

Conditions

  • Efficacy and Safety of Novel Bidirectional Cannula

Interventions

DEVICE

Novel bidirectional cannula (BiflowTM, LivaNova, Italy)

We are going to evaluate the safety and efficacy of the novel bidirectional cannula (BiflowTM, LivaNova, Italy) with specific design to ensure stable distal perfusion compared to conventional cannula with downstream line in patients undergoing femoral arterial cannulation for CPB during minimally invasive surgery

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    lead OTHER

Principal Investigators

  • Serdar Gunaydin, MD · Ankara City Hospital Bilkent

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-06-15
Completion
2020-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04402372 on ClinicalTrials.gov